Schiewe Mitchel C, Whitney John B, Anderson Robert E
Southern California Institute for Reproductive Sciences, Newport Beach, California.
Southern California Institute for Reproductive Sciences, Newport Beach, California.
Fertil Steril. 2015 Feb;103(2):417-21. doi: 10.1016/j.fertnstert.2014.11.009. Epub 2014 Dec 13.
To document the risk of in vitro monochorionic dizygotic twin formation in the implementation of a program of blastocyst biopsy with preimplantation genetic screening (PGS).
Case report.
Private infertility laboratory.
PATIENT(S): Prospective PGS patients with intracytoplasmic sperm injection-derived, group-cultured blastocysts over a 3-year period.
INTERVENTION(S): Group culture in Global medium (Life Global) to optimize blastocyst formation of zygotes produced for blastocyst biopsy for PGS (n ≤ 8 embryos/25 μL droplet), and laser zona dissection (LZD) of all day-3 cleaved embryos to promote pre-expansion trophectodermal extrusion at the blastocyst stage (i.e., premature hatching).
MAIN OUTCOME MEASURE(S): Blastocyst formation and quality grading on days 5 and 6 of in vitro culture for the vitrified embryo transfer of single or dual euploid blastocysts.
RESULT(S): Over 3,000 blastocysts were produced in vitro. On two separate occasions, complete trophectodermal amalgamation was observed between two hatching blastocysts. Vitrified single-euploid blastocyst transfers efficiently implanted and established clinical pregnancies similar to dual-euploid blastocyst transfers, without the risk of twin formation.
CONCLUSION(S): The amazing occurrence of monochorionic dizygotic twin formation has now been documented in vitro, supporting the theory that assisted reproductive technology may facilitate this rare perinatal condition. Furthermore, we have provided clinical evidence that the transfer of a single-euploid blastocyst can optimize a patient's pregnancy success while reducing potentially undesirable conditions associated with monochorionic twin pregnancies.
记录在实施囊胚活检与植入前基因筛查(PGS)程序过程中体外形成单绒毛膜双卵双胎的风险。
病例报告。
私立不孕不育实验室。
在3年期间接受PGS的前瞻性患者,其囊胚由胞浆内单精子注射获得并进行群体培养。
在Global培养基(Life Global)中进行群体培养,以优化用于PGS囊胚活检的受精卵的囊胚形成(每个25μL液滴中n≤8个胚胎),并对所有第3天的分裂期胚胎进行激光 zona 切割(LZD),以促进囊胚期滋养外胚层提前挤出(即过早孵化)。
用于单倍体或双倍体正常囊胚玻璃化胚胎移植的体外培养第5天和第6天的囊胚形成及质量分级。
体外产生了超过3000个囊胚。在两个不同的场合,观察到两个孵化中的囊胚之间完全的滋养外胚层融合。玻璃化单倍体正常囊胚移植有效地着床并建立了与双倍体正常囊胚移植相似的临床妊娠,且没有双胎形成的风险。
现已记录到体外惊人地出现了单绒毛膜双卵双胎形成,支持了辅助生殖技术可能促成这种罕见围产期情况的理论。此外,我们提供了临床证据,即单倍体正常囊胚移植可以优化患者的妊娠成功率,同时减少与单绒毛膜双胎妊娠相关的潜在不良情况。